Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RITA B CHUANG

Allopathic & Osteopathic Physicians Family Medicine

NPI
1497854962
CMS profile
339716
Location
HENDERSON, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$1,935.28

96 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,935.28 96

By paying entity

PY2021 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RITA B CHUANG

NPI 1497854962 · CMS profile ID 339716

Allopathic & Osteopathic Physicians / Family Medicine

HENDERSON, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1497854962?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RITA B CHUANG, NPI 1497854962, CMS profile ID 339716. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1497854962?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). RITA B CHUANG, NPI 1497854962, CMS profile ID 339716. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1497854962?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
RITA B CHUANG, NPI 1497854962, CMS profile ID 339716, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 96 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1497854962?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

96 matching records · $1,935.28 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 96 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 96.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $8.7112/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818676949 CMS
Amarin Pharma Inc. $22.4912/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815115363 CMS
Merck Sharp & Dohme Corporation $16.6712/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848402921 CMS
PFIZER INC. $23.0012/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833168723 CMS
Novo Nordisk Inc $20.8511/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811681883 CMS
Esperion Therapeutics, Inc. $22.3711/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838267071 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.5311/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850188287 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.4111/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763702272 CMS
GlaxoSmithKline, LLC. $12.1011/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801593953 CMS
Amgen Inc. $18.8811/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826418777 CMS
AstraZeneca Pharmaceuticals LP $22.0911/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830088511 CMS
Lilly USA, LLC $9.9911/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818692837 CMS
Biohaven Pharmaceuticals, Inc. $18.2110/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852461715 CMS
PFIZER INC. $22.1610/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833585435 CMS
DEXCOM, INC. $15.8110/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845273183 CMS
Eisai Inc. $19.8710/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818021683 CMS
Esperion Therapeutics, Inc. $15.0010/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838267067 CMS
AbbVie Inc. $24.6510/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794259209 CMS
PFIZER INC. $21.1610/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832982774 CMS
AstraZeneca Pharmaceuticals LP $13.7510/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829328843 CMS
Novo Nordisk Inc $15.0510/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811681881 CMS
Lilly USA, LLC $11.8109/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818676947 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.3409/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763702274 CMS
GlaxoSmithKline, LLC. $16.2609/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802370573 CMS
Amgen Inc. $14.2409/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825726339 CMS
Amgen Inc. $10.3709/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825726351 CMS
AstraZeneca Pharmaceuticals LP $125.1109/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830088639 CMS
PFIZER INC. $14.5209/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833512185 CMS
AstraZeneca Pharmaceuticals LP $21.1109/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829608261 CMS
GlaxoSmithKline, LLC. $25.0509/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803073481 CMS
AstraZeneca Pharmaceuticals LP $13.5409/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829730737 CMS
Biohaven Pharmaceuticals, Inc. $18.2108/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852461711 CMS
Novo Nordisk Inc $24.9808/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811281415 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.4108/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763702276 CMS
GENZYME CORPORATION $123.2308/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843543437 CMS
DEXCOM, INC. $16.2408/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845273181 CMS
Esperion Therapeutics, Inc. $18.0008/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838267063 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.0908/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850117161 CMS
AstraZeneca Pharmaceuticals LP $17.0708/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829870113 CMS
Lilly USA, LLC $13.2908/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818713123 CMS
PFIZER INC. $24.2307/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832777161 CMS
PFIZER INC. $19.8107/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833504513 CMS
AbbVie Inc. $11.2207/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794259207 CMS
Lilly USA, LLC $8.8207/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 856542983 CMS
DEXCOM, INC. $14.0107/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845273179 CMS
Lilly USA, LLC $13.9507/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818739383 CMS
AbbVie Inc. $21.5907/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794259205 CMS
AstraZeneca Pharmaceuticals LP $12.9007/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829556677 CMS
PFIZER INC. $12.9806/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833391071 CMS
Janssen Pharmaceuticals, Inc $12.3706/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788320201 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,839.57 139
PY2020 $1,433.13 89
PY2021 $1,935.28 96
PY2022 $1,401.79 64
PY2023 $3,265.71 67
PY2024 $1,619.65 16
PY2025 $876.10 8

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $109,405.49 16
PY2021 Principal investigator $79,823.05 120
PY2020 Principal investigator $98,717.42 98
PY2019 Recipient $901.66 10
PY2019 Principal investigator $172,883.69 87

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

120 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $2,703.96 09/24/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470817
Principal investigator 1 Novo Nordisk AS $139.34 09/10/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721499
Principal investigator 1 Novo Nordisk AS $4,241.88 08/30/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721417
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $15,094.00 08/12/2021 Non-covered Recipient Entity
SYNEXUS - RITA CHUANG
C3718-301 No dispute reported 06/30/2026 831591957
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $1,804.00 08/12/2021 Non-covered Recipient Entity
SYNEXUS - RITA CHUANG
C3718-301 No dispute reported 06/30/2026 831591967
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $9,473.00 08/12/2021 Non-covered Recipient Entity
SYNEXUS - RITA CHUANG
C3718-301 No dispute reported 06/30/2026 831596639
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $5,743.00 08/12/2021 Non-covered Recipient Entity
SYNEXUS - RITA CHUANG
C3718-301 No dispute reported 06/30/2026 831596647
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $1,500.00 08/12/2021 Non-covered Recipient Entity
SYNEXUS - RITA CHUANG
C3718-301 No dispute reported 06/30/2026 831597911
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $9,351.00 08/12/2021 Non-covered Recipient Entity
SYNEXUS - RITA CHUANG
C3718-301 No dispute reported 06/30/2026 831599233
Principal investigator 1 Novo Nordisk AS $1,800.00 07/28/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721397
Principal investigator 1 Novo Nordisk AS $350.00 07/28/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721407
Principal investigator 1 Novo Nordisk AS $2,846.88 06/28/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799563
Principal investigator 1 Novo Nordisk AS $2,748.96 05/28/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811471766
Principal investigator 1 Novo Nordisk AS $2,621.88 04/26/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721519
Principal investigator 1 Novo Nordisk AS $250.00 03/24/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721509
Principal investigator 1 Novo Nordisk AS $5,551.20 03/24/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799553
Principal investigator 1 Allergan, Inc. $1,500.00 03/01/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789022121
Principal investigator 1 Novo Nordisk AS $138.85 02/26/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721483
Principal investigator 1 Novo Nordisk AS $39.50 02/26/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721493
Principal investigator 1 Novo Nordisk AS $144.00 02/26/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799533
Principal investigator 1 Novo Nordisk AS $15.60 02/26/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810801957
Principal investigator 1 Novo Nordisk AS $74.95 02/26/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325591
Principal investigator 1 Novo Nordisk AS $65.34 02/26/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811471747
Principal investigator 1 Novo Nordisk AS $38.94 02/26/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811471755
Principal investigator 1 Novo Nordisk AS $368.75 02/22/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799543
Principal investigator 1 Novo Nordisk AS $5,283.36 02/22/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811331387
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721301
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721311
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721321
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721331
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721341
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721351
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721361
Principal investigator 1 Novo Nordisk AS $7.90 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721369
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721377
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721387
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721427
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721437
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721443
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721453
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721463
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810721473
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810724143
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810724153
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810724163
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810724173
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799277
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799287
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799297
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799307
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799317
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799327
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799337
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799347
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799355
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799364
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799374
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799385
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799395
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799405
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799417
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799427
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799437
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799445
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799455
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799465
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799473
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799483
Principal investigator 1 Novo Nordisk AS $14.99 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799493
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799503
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799513
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810799523
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810801917
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810801937
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 810801947
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325249
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325257
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325439
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325449
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325459
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325469
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325479
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325487
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325497
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325506
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325515
Principal investigator 1 Novo Nordisk AS $9.15 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325525
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325535
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325545
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325555
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325563
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325571
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325581
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811331377
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811469437
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811469447
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470695
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470703
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470711
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470721
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470731
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470741
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470747
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470757
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470767
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470777
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470787
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470797
Principal investigator 1 Novo Nordisk AS $36.00 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470807
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470827
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470835
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470843
Principal investigator 1 Novo Nordisk AS $11.38 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811470853
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811471725
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811471735
Principal investigator 1 Novo Nordisk AS $5.30 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811480441
Principal investigator 1 Novo Nordisk AS $16.25 02/16/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811480451
Principal investigator 1 Novo Nordisk AS $1,350.00 01/28/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC.
EX9536-4388 No dispute reported 06/30/2026 811325239
Principal investigator 1 Eli Lilly and Company $2,863.71 01/26/2021 Non-covered Recipient Entity
CLINICAL RESEARCH ADVANTAGE
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE No dispute reported 06/30/2026 819454059
Principal investigator 1 Allergan, Inc. $668.75 01/18/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789022119